Subscribe To Our Free Newsletter |
Here’s why Vinit Sambre is bullish on pharma sector
Clients' decision making is a bit delayed. But what these managements were sort of also alluding to was the fact that the deal pipeline looks okay which I think anyways when we look at the numbers most of the companies if one focuses on the deal pipeline those are okay.